Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2010
07/28/2010CN101790380A Conjugates of synthetic tlr agonists and uses therefor
07/28/2010CN101787358A Tet-Off Advanced human stably expressing high-transition nasopharyngeal carcinoma cell line S18, construction method thereof and application thereof
07/28/2010CN101787116A Compound and application thereof in preparing drug for curing viral respiratory infection
07/28/2010CN101787073A Methods and compositions for the treatment of gastrointestinal disorders
07/28/2010CN101787063A Anti-infective medicament and preparation and application thereof
07/28/2010CN101785839A Traditional Chinese medicine combination and preparation method thereof for hemoptysis treatment
07/28/2010CN101785838A Lung cancer treatment medicine
07/28/2010CN101785826A Thunberg fritillary flower micropowder preparation method
07/28/2010CN101785803A Composition for suppressing cyclooxygenase and/or 5-lipoxygenase
07/28/2010CN101785796A Method for preparing Jingan capsules
07/28/2010CN101785789A Method for preparing animal gall powder
07/28/2010CN101785581A Smoking-cessation and health-care cigarette holders and using method thereof
07/28/2010CN101292976B Medicament combination containing 1,8-eudesmin and flavanones, and uses thereof
07/28/2010CN101209334B Lung cancer-treating medicament and preparation thereof
07/27/2010US7763752 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
07/27/2010US7763729 Bicyclic heteroaromatic derivatives
07/27/2010US7763632 administering drugs succh as N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl) carbonyloxy}phenylalanine, for the treament asthma, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, graft versus host disease and arthritis
07/27/2010US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
07/27/2010US7763617 Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient
07/27/2010US7763610 cysteinyl leukotriene antagonists such as 4-(3-carboxypropyl)-8-((4-(4-phenylbutoxy)benzoyl)amino)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid, used for treating asthma, chronic obstructive pulmonary disease, pneumonia, rhinitis and as expectorants or antitussives
07/27/2010US7763597 Salts
07/27/2010CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors
07/27/2010CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
07/27/2010CA2448456C Solid pharmaceutical formulations comprising modafinil
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2401331C Methods and devices for use in performing pulmonary procedures
07/22/2010WO2010083133A1 Compositions and methods for the treatment of throat discomfort
07/22/2010WO2010082531A1 Active blood coagulation factor inhibitor
07/22/2010WO2010081232A1 Honey product having a low water content
07/22/2010WO2010015586A3 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds
07/22/2010WO2009093127A3 Substantially pure and a stable crystalline form of bosentan
07/22/2010US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses
07/22/2010US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue
07/22/2010US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
07/22/2010US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof
07/22/2010US20100184783 Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
07/22/2010US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2010US20100184767 Substituted oxazolidinones and use thereof
07/22/2010US20100184760 Benzoxazole kinase inhibitors and methods of use
07/22/2010US20100184749 Benzothiadiazine compounds and their use
07/22/2010US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs
07/22/2010US20100184739 Modulators of ATP-Binding Cassette Transporters
07/22/2010US20100184736 Treatment of Meconium Aspiration Syndrome with Estrogens
07/22/2010US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives
07/22/2010US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent
07/22/2010US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent
07/22/2010US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent
07/22/2010US20100184696 Peptides and Their Use
07/22/2010US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin
07/22/2010US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43
07/22/2010US20100184679 Use of a combination of cart peptides as a therapeutic agent
07/22/2010US20100184678 Use of a peptide as a therapeutic agent
07/22/2010US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent
07/22/2010US20100184676 Use of a peptide as a therapeutic agent
07/22/2010US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
07/22/2010US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent
07/22/2010US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
07/22/2010US20100184646 Melanocortin receptor ligands modified with hydantoin
07/22/2010US20100184644 Mucosal repair by tff dimer peptides
07/22/2010US20100184019 Novel Human Virus Causing Severe Acute Respiratory Syndrome (SARS) and Uses Thereof
07/22/2010US20100183729 Novel Process
07/22/2010US20100183721 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183619 Neutralizing Antibodies and Methods of Use Thereof
07/22/2010CA2749871A1 Honey product having a low water content
07/22/2010CA2749133A1 Compositions and methods for the treatment of throat discomfort
07/21/2010EP2208499A1 Nucleic acid capable of regulating the proliferation of cell
07/21/2010EP2207808A1 Improved nogo-a binding molecules and pharmaceutical use thereof
07/21/2010EP2207801A1 Methods of inhibiting viral infection
07/21/2010EP2207780A1 Thienopyrimidine compounds and compositions
07/21/2010EP2207597A2 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
07/21/2010EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent
07/21/2010EP2207538A1 Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti -inflammatory and the use thereof for the treatment of respiratory disorders
07/21/2010EP2207527A2 Methods for administering corticosteroid formulations
07/21/2010EP1265928B1 Ultra high affinity rsv neutralizing antibodies
07/21/2010EP1079825B1 Compounds that inhibit the binding of integrins to their receptors
07/21/2010EP0748228B1 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM
07/21/2010CN1730034B Pharmaceutical composition for treating acute pneumonia, urinary tract infection and cholecystitis
07/21/2010CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
07/21/2010CN101784302A A modulator of nrg1 for treatment of respiratory disorders
07/21/2010CN101781373A Salbutamol modified guanidinated chitosan and preparation method and application thereof
07/21/2010CN101781364A Interleukin-1 receptor antagonist
07/21/2010CN101781348A Stable protein kinase activator, preparation method thereof and use
07/21/2010CN101780271A Medicinal composition of endotoxin and lectin and application thereof
07/21/2010CN101780270A Compound soluble powder for treating respiratory diseases of birds
07/21/2010CN101780269A Application of cell growth factor in treatment of ulcerative diseases and pulmonary fibrosis
07/21/2010CN101780266A Compound preparation for preventing and treating respiratory disease of livestock and poultry
07/21/2010CN101780264A Traditional Chinese medicine for preventing cold
07/21/2010CN101780238A Traditional Chinese medicine composition for treating asthma and preparation method thereof
07/21/2010CN101780237A Traditional Chinese medicine composition for treating cough and preparation method thereof
07/21/2010CN101780214A Method for preparing granules for curing infantile lung pathogenic heat and cough and asthma
07/21/2010CN101780211A Traditional Chinese medicine for treating infantile chronic cough and asthma
07/21/2010CN101780180A Preparation method of traditional Chinese medicine for treating early pulmonary abscess
07/21/2010CN101780175A Method for extracting and preparing total flavones of datura stramonium seed
07/21/2010CN101780174A Internal medicine combined with Chinese and western medicine for curing allergic rhinitis and preparation method thereof
07/21/2010CN101780167A Chinese medicine compound for preventing and curing lung diseases and clearing human body toxin and preparation method thereof
07/21/2010CN101780151A TCM preparation for treating pulmonary heart disease
07/21/2010CN101780150A Plant extract and pharmaceutical composition for treating cough and preparation method thereof
07/21/2010CN101780148A Nymphaea tetragona chewable tablet and preparation method thereof